TruTag Technologies’ Manufacturing Plant Achieves GMP Compliance

Published on: 

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016, Volume 11, Issue 9

The GMP-certified facility will produce TruTag microtags for global pharmaceutical customers.

TruTag Technologies announced that its silica microtag manufacturing facility in Kapolei, Hawaii has achieved compliance with current good manufacturing practices (cGMP) for the manufacturing of TruTag microtags for pharmaceutical and food products for global manufacturers and brand owners. The facility was audited by a third party and meets the requirements of the International Pharmaceutical Excipients Council guidelines.

TruTags are covert, edible, and encrypted optical memory devices made from pure silicon dioxide (silica), a material that is considered “generally recognized as safe” (GRAS) by FDA. TruTags enable the digitization of medicine and food so that customers can identify, authenticate, and track products throughout the global supply chain. TruTags serve as a digital cookie for analog products. According to the company, when TruTags are applied to products, manufacturers are able to assess the provenance of each item and collect information such as manufacturing site, dosage, authorized distribution channel, lot numbers, and other valuable information including the entire drug package insert or related safety information, if needed.

TruTag’s manufacturing facility is the world’s largest cGMP nano-porous silica production plant and houses the company’s application engineering and advanced materials research center. TruTag’s cGMP facility features fully automated and robotics-enhanced production lines.


Source: TruTag Technologies